- In December 2024, Co-Diagnostics, Inc. and its Indian joint venture, CoSara Diagnostics Pvt. Ltd., inaugurated CoSara's oligonucleotide synthesis facility in Ranoli, India. This new facility is designed to support the "Make in India" initiative by manufacturing the company's patented Co-Primers chemistry, which underpins Co-Dx's and CoSara's lab-based PCR diagnostic tests
- In November 2023, Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, launched Twist Express Genes. This new gene synthesis service boasts a rapid order-to-shipping turnaround time of five to seven business days, significantly accelerating research and development workflows in gene editing, drug discovery, and other genomic applications
- In October 2023, Integrated DNA Technologies (IDT), an operating company in the Life Sciences segment of Danaher Corporation, announced the completion of its new Therapeutic Oligonucleotide Manufacturing facility in Coralville, Iowa. This significant milestone marks IDT's entrance into the therapeutics space, enabling the manufacture of cGMP-grade cell and gene therapy reagents to support the growing demand in genomic medicine
- In May 2023, Twist Bioscience Corporation and CeGaT GmbH announced a collaboration to launch the Twist Alliance CeGaT RNA Fusion Panel. This joint effort aims to provide a specialized tool for oncology research, facilitating the efficient detection of RNA fusions and enabling transcript variant analysis in cancer studies, showcasing increasing collaboration in targeted research solutions
- In February 2023, Fluor Corporation announced it was selected by Agilent Technologies, Inc. to provide engineering and procurement services for the expansion of Agilent's oligonucleotide therapeutics manufacturing facility in Frederick, Colorado. This collaboration signifies a major investment in expanding large-scale production capabilities for therapeutic oligonucleotides, critical for meeting the growing demand in genetic medicine
